Cargando…

SABINA: An Overview of Short-Acting β(2)-Agonist Use in Asthma in European Countries

INTRODUCTION: Globally, individuals with asthma tend to overrely on short-acting β(2)-agonists (SABAs) and underuse inhaled corticosteroids, thereby undertreating the underlying inflammation. Such relief-seeking behavior has been reinforced by long-standing treatment guidelines, which until recently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janson, Christer, Menzies-Gow, Andrew, Nan, Cassandra, Nuevo, Javier, Papi, Alberto, Quint, Jennifer K., Quirce, Santiago, Vogelmeier, Claus F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089727/ https://www.ncbi.nlm.nih.gov/pubmed/31981105 http://dx.doi.org/10.1007/s12325-020-01233-0

Ejemplares similares

Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior
por: Morgan, Ann, et al.
Publicado: (2023)

Short‐acting β(2)‐agonist use and asthma exacerbations in Swedish children: A SABINA Junior study
por: Melén, Erik, et al.
Publicado: (2022)

Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
por: Molina, Jesús, et al.
Publicado: (2023)

Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study
por: Attar-Zadeh, Darush, et al.
Publicado: (2023)

Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
por: Nwaru, Bright I., et al.
Publicado: (2020)

The Burden of Short-Acting β(2)-Agonist Use in Asthma: Is There an Italian Case? An Update from SABINA Program
por: Di Marco, Fabiano, et al.
Publicado: (2021)

Short-acting β(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
por: Yorgancıoğlu, Arzu, et al.
Publicado: (2022)

Short-acting β(2)-agonist prescription patterns for asthma management in the SABINA III primary care cohort
por: Price, David, et al.
Publicado: (2022)

Over-prescription of short-acting β(2)-agonists for asthma in South Africa: Results from the SABINA III study
por: Smith, C, et al.
Publicado: (2022)

Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
por: Bateman, Eric D., et al.
Publicado: (2022)

The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme
por: Janson, Christer, et al.
Publicado: (2022)

Overprescription of short‐acting β(2)‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study
por: Al‐Jahdali, Hamdan, et al.
Publicado: (2022)

Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme
por: Bao, Wuping, et al.
Publicado: (2022)

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia
por: Wang, Hao-Chien, et al.
Publicado: (2023)

Sabina
por: Buide, Mario, 1913-
Publicado: (1983)

Sabina
por: Emory, W. J. Hunter
Publicado: (1888)

A Cross-Sectional Study on Prescription Patterns of Short-Acting β(2)-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort
por: Pedrozo-Pupo, John Carlos, et al.
Publicado: (2022)

María Sabina
por: Cela, Camilo José, 1916-2002
Publicado: (1970)

Sabina : una novela biográfica
por: Alnaes, Karsten 1930-
Publicado: (1996)

Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme
por: Wilkinson, Alex, et al.
Publicado: (2022)

Joaquín Sabina : perdonen la tristeza /
por: Menéndez Flores, Javier, 1969-

Revisiting Late-Onset Asthma: Clinical Characteristics and Association with Allergy
por: Quirce, Santiago, et al.
Publicado: (2020)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
por: Worth, Heinrich, et al.
Publicado: (2021)

Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores
por: Menzies-Gow, Andrew, et al.
Publicado: (2017)

Over-prescription of short-acting β(2)-agonists remains a serious health concern in Kenya: results from the SABINA III study
por: Chakaya, Jeremiah, et al.
Publicado: (2023)

SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
por: Noorduyn, Stephen G., et al.
Publicado: (2022)

María Sabina : la tradición de los hongos sagrados entre los curanderos mazatecos
por: González Rubio Montoya, Enrique, 1953-
Publicado: (2019)

Vida de María Sabina : la sabia de los hongos /
por: Estrada, Alvaro
Publicado: (1997)

Sabina Faiz Rashid: research on community resilience
Publicado: (2020)

High use of short-acting β(2)-agonists in COPD is associated with an increased risk of exacerbations and mortality
por: Janson, Christer, et al.
Publicado: (2023)

Understanding relationships between asthma medication use and outcomes in a SABINA primary care database study
por: Vervloet, Marcia, et al.
Publicado: (2022)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
por: Scichilone, Nicola, et al.
Publicado: (2014)

La vida de María Sabina : la sabia de los hongos
por: Estrada, Alvarado
Publicado: (1977)

El ojo de agua de Sabinas Hidalgo /
por: Garza Guajardo, Celso
Publicado: (1981)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD
por: Tomaszewski, Erin L., et al.
Publicado: (2023)

Diagnosis and Management of Grain-Induced Asthma
por: Quirce, Santiago, et al.
Publicado: (2013)

SABA Overuse in Russia – Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study
por: Avdeev, Sergey, et al.
Publicado: (2022)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

The Biology of Eosinophils and Their Role in Asthma
por: McBrien, Claire N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3h9jalh5l3gkqc4or1d6dfp11q